Adipose derived mesenchymal stem cells (ASCs) transplantation is a novel immunomodulatory therapeutic tool to ameliorate the symptom of inflammatory bowel disease (IBD). The objective of this study was to investigate the therapeutic effects of combined sufasalazine and ASCs therapy in a rat model of IBD. After induction of colitis in rats, ASCs were cultured and intraperitoneally injected (3 × 10 6 cells/kg) into the rats on Days 1 and 5 after inducing colitis, in conjunction with daily oral administration of low dose of sulfasalazine (30 mg/kg). The regenerative effects of combination of ASCs and sulfasalazine on ulcerative colitis were assessed by measuring body weight, colonic weight/length ratio, disease activity index, macroscopic scor...
Inflammatory bowel diseases (IBDs) cause significant morbidity and mortality. Aberrant NF-κB signall...
The mode of action of sulphasalazine (SASP) and balsalazide (BSZ), therapeutic agents of inflammator...
Purpose An herbal preparation, STW 5, used clinically in functional dyspepsia and irritable bowel sy...
Objective: This study targets the inhibition of inflammatory mediators and the enhancement of gastro...
The 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced acute inflammatory bowel disease (IBD) model i...
Background: There is no cure for autoimmune chronic inflammatory bowel disease (IBD). IBD patients c...
Background: Inflammatory bowel disease (IBD) is an idiopathic, chronic inflammatory condition, which...
peer reviewedBACKGROUND AND AIM: AZD8055, a new immunosuppressive reagent, a dual TORC1/2 inhibitor,...
  Objective: Inflammatory bowel disease (IBD) is a disorder characterized by chronic inflammation ...
Ulcerative colitis (UC) is a common chronic remitting disease but without satisfactory treat-ment. A...
Objective(s): Ulcerative colitis (UC) remains an enduring, idiopathic inflammatory bowel disease mar...
Inflammatory bowel diseases (IBD) are chronic, immune-mediated disorders, which affect the gastroint...
ObjectiveInflammatory bowel diseases cause significant morbidity and mortality. Aberrant NF-κB signa...
PURPOSE: To determine whether simvastatin is able to inhibit inflammation in trinitrobenzene sulfoni...
BACKGROUND/AIMS: Bone marrow-derived mesenchymal stem cells (BM-MSCs) have shown beneficial effects ...
Inflammatory bowel diseases (IBDs) cause significant morbidity and mortality. Aberrant NF-κB signall...
The mode of action of sulphasalazine (SASP) and balsalazide (BSZ), therapeutic agents of inflammator...
Purpose An herbal preparation, STW 5, used clinically in functional dyspepsia and irritable bowel sy...
Objective: This study targets the inhibition of inflammatory mediators and the enhancement of gastro...
The 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced acute inflammatory bowel disease (IBD) model i...
Background: There is no cure for autoimmune chronic inflammatory bowel disease (IBD). IBD patients c...
Background: Inflammatory bowel disease (IBD) is an idiopathic, chronic inflammatory condition, which...
peer reviewedBACKGROUND AND AIM: AZD8055, a new immunosuppressive reagent, a dual TORC1/2 inhibitor,...
  Objective: Inflammatory bowel disease (IBD) is a disorder characterized by chronic inflammation ...
Ulcerative colitis (UC) is a common chronic remitting disease but without satisfactory treat-ment. A...
Objective(s): Ulcerative colitis (UC) remains an enduring, idiopathic inflammatory bowel disease mar...
Inflammatory bowel diseases (IBD) are chronic, immune-mediated disorders, which affect the gastroint...
ObjectiveInflammatory bowel diseases cause significant morbidity and mortality. Aberrant NF-κB signa...
PURPOSE: To determine whether simvastatin is able to inhibit inflammation in trinitrobenzene sulfoni...
BACKGROUND/AIMS: Bone marrow-derived mesenchymal stem cells (BM-MSCs) have shown beneficial effects ...
Inflammatory bowel diseases (IBDs) cause significant morbidity and mortality. Aberrant NF-κB signall...
The mode of action of sulphasalazine (SASP) and balsalazide (BSZ), therapeutic agents of inflammator...
Purpose An herbal preparation, STW 5, used clinically in functional dyspepsia and irritable bowel sy...